Virginia Ruiz-Esquide Selected Research

Palindromic rheumatism

1/2020	Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis.
1/2017	Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis.
8/2014	Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? a clinical and ultrasonographic study according to anticitrullinated protein antibody status.
10/2012	Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virginia Ruiz-Esquide Research Topics

Disease

22	Rheumatoid Arthritis 05/2022 - 04/2011
5	Psoriatic Arthritis 12/2018 - 01/2014
4	Palindromic rheumatism 01/2020 - 10/2012
3	Synovitis 01/2022 - 08/2014
2	Arthritis (Polyarthritis) 01/2022 - 01/2014
2	Inflammation (Inflammations) 07/2021 - 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Osteoporosis 03/2019
1	Infections 03/2019
1	Human Influenza (Influenza) 03/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2018
1	Body Weight (Weight, Body) 01/2018
1	Edema (Dropsy) 12/2017
1	Joint Diseases (Joint Disease) 01/2016
1	Neoplasms (Cancer) 01/2016
1	Necrosis 01/2016
1	Colitis 01/2016
1	Melanoma (Melanoma, Malignant) 01/2016
1	Rheumatic Diseases (Rheumatism) 01/2014
1	Ankylosing Spondylitis 01/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2012
1	Sarcoidosis (Schaumann Disease) 04/2011
1	Pulmonary Sarcoidosis 04/2011
1	Obesity 02/2011
1	Malnutrition (Nutritional Deficiencies) 02/2011

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 09/2021 - 07/2012
5	AntibodiesIBA 01/2022 - 07/2012
5	tocilizumab (atlizumab)FDA Link 10/2020 - 12/2015
5	Peptides (Polypeptides)IBA 01/2020 - 07/2012
5	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2018 - 12/2015
4	Biomarkers (Surrogate Marker)IBA 07/2021 - 12/2017
3	C-Reactive ProteinIBA 01/2022 - 01/2016
3	Tumor Necrosis Factor InhibitorsIBA 12/2018 - 04/2011
3	Etanercept (Enbrel)FDA Link 01/2016 - 04/2011
3	Infliximab (Remicade)FDA Link 01/2016 - 04/2011
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2016 - 12/2015
3	Adalimumab (Humira)FDA Link 01/2016 - 04/2011
2	AutoantibodiesIBA 05/2022 - 01/2020
2	Monoclonal AntibodiesIBA 10/2020 - 04/2011
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Antirheumatic Agents (DMARD)IBA 01/2022
1	Abatacept (Orencia)FDA Link 09/2021
1	Anti-Idiotypic AntibodiesIBA 01/2020
1	Vitamin D FDA LinkGeneric 03/2019
1	EpitopesIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2016
1	Immune Checkpoint InhibitorsIBA 01/2016
1	IpilimumabIBA 01/2016
1	Biological ProductsIBA 01/2014
1	CytokinesIBA 11/2013
1	Anti-Citrullinated Protein AntibodiesIBA 07/2012
1	VitaminsIBA 02/2011
1	CalciumIBA 02/2011
1	MicronutrientsIBA 02/2011

Therapy/Procedure

4	Therapeutics 01/2022 - 04/2011
2	Drug Tapering 10/2020 - 01/2014
1	Biological Therapy 01/2014
1	Bariatric Surgery 02/2011